In late 2022, ProxsysRx’s team initiated 340B Program-Management support for a regional non-profit medical center located in the Northeast. We began actively submitting eligible prescriptions in January, 2023. By the end of Q1, the hospital’s 2023 340B savings & revenue had surpassed its total for all of 2022. Below is a brief review of how we managed to achieve those results.
Laying The Hospital’s 340B Program Groundwork
The hospital had not updated their list of providers since 2021. As a rule, ProxsysRx updates provider lists for the 340B programs we manage on a monthly basis. Once we had a fully-updated provider list, we sent it to each of the three TPAs they use.
Requalifying eligible scripts
With the hospital’s updated provider list in its TPA’s systems, we set-about requalifying (with those TPAs) still-eligible scripts written by its providers.
Retrieving eligible-script data
The hospital’s data team assembled and delivered the hospital’s historical 340B-program files. They set up the feeds, and our data team provided a template for “translating” that data into our 340B PRO software system. Once that process was working smoothly, the hospital’s script data came to our 340B team ready to be re-qualified.
Initiating weekly contact between our respective 340B teams
In January, ProxsysRx’s 340B team leader began conducting twice-weekly calls with the hospital’s 340B team leader.
“Most of the time,” he says, “she’ll have several questions and / or issues for us on Monday. By the time our Friday call rolls around, we’ve typically answered her questions and worked-out the issues — at which point, we’ll spend that call reviewing what we’ve done during the week.”
Working with the hospital’s 340B contract-pharmacy network
The hospital has a total of 110 contract pharmacies in its network — mostly retail, but also including specialty pharmacies and mail-order pharmacies, as well as an infusion clinic; yet another reason why ProxsysRx’s 340B PRO software is so critical to our successfully managing the myriad details and data points involved in any health system’s 340B program.
“The hospital hadn’t updated designations for its contract pharmacy network since March 16, 2022, so that was another critical element to the success we’ve enjoyed.”
Looking ahead to the hospital’s 340B savings & revenue future
“Given how far back we mined the hospital’s script data for requalification, we don’t anticipate sustained year-over-year increases of 400%. At the same time, we have enjoyed consistent success in generating exceptional year-over-year increases well into the second quarter. And at the end of the day, serving our clients to the absolute best of our ability is why we do this.”
ProxsysRx is here to help, if you have questions.
For more information, contact Howard Hall. C: 214.808.2700 | howard.hall@proxsysrx.com
